Spectrometry News and Research

RSS

AB SCIEX announces formal opening of Asia Pacific Application Support Center in Shanghai

AB SCIEX, a global leader in life science analytical technologies, today announced the formal opening of its Asia Pacific Application Support Center in Shanghai. With state-of-the-art, award-winning facilities, the new Application Support Center serves as a regional center of excellence for comprehensive service, support and application development to enable the science community in China and the region to continue its increasing use of mass spectrometry and complementary technologies for a broad range of applications.

12 Apr 2010

NMS Labs launches test to evaluate the efficacy of Milnacipran

NMS Labs launches another unique test suitable for the evaluation of toxicity vs. efficacy, the potential for physicians to establish therapeutic drug monitoring of individual patients, and the assessment of drug diversion of a new pain management drug therapy.

31 Mar 2010

BIOCIUS Life Sciences executes lease agreement for new Corporate Headquarters in Wakefield, MA

BIOCIUS Life Sciences Inc., developers of the RapidFire® high-throughput mass spectrometry system, today announced execution of a lease agreement for a new Corporate Headquarters in Wakefield, MA. The new facility located at 11 Audubon Road doubles the company's capacity and is a result of the increase in demand for RapidFire products and services.

30 Mar 2010

ACS webinar on chemistry for food safety

Scheduled for Thursday, April 1, 2 - 3 p.m. Eastern Time, the free webinar will feature Walter Hammack with the Florida Department of Agriculture, as he discusses the various chromatographic tools, methods and regulations for food safety. His topic: "How Chemistry is Keeping Your Food Safe -Application of Ultra High Pressure Liquid Chromatography (UHPLC) in a Food Safety Laboratory."

24 Mar 2010

Pressure BioSciences announces presentations on advantages of PCT

Pressure BioSciences, Inc. today announced that five presentations on the advantages of pressure cycling technology (PCT) in the preparation, processing, identification, and quantification of proteins were made at last week's annual meeting of US HUPO (Human Proteomics Organization) in Denver, Colorado.

From Thermo Fisher Scientific Inc. 19 Mar 2010

Forensic Laboratories introduces first oral fluid test for Tapentadol

Forensic Laboratories, a Denver-based laboratory specializing in toxicology services for drug abuse, has unveiled the first oral fluid test for Tapentadol, a new federally approved drug prescribed by doctors for pain management. Previously, laboratories could only detect the drug through urine using liquid chromatography-mass spectrometry-mass spectrometry (LC/MS/MS) technology.

15 Mar 2010

Metal implants in young mothers may pose danger to offspring

Women with metal-on-metal hip implants, where both the ball of the joint and the surface of the socket are made of metal, pass metal ions to their offspring during pregnancy, according to a study by researchers at Rush University Medical Center. The ions are the result of wear and corrosion as the metal parts rub against one another.

11 Mar 2010

PBI and TDI announce strategic licensing and collaborative research and development agreement

Pressure BioSciences, Inc. and Target Discovery, Inc.,, today announced a strategic product licensing, manufacturing, co-marketing, and collaborative research and development agreement. Under the terms of the Agreement, PBI has been licensed by TDI to manufacture and sell a highly innovative line of chemicals used in the preparation of tissues for scientific analysis.

11 Mar 2010

BIOCRATES Life Sciences, CHENOMX announce co-marketing agreement

Austrian biomarker developer BIOCRATES Life Sciences AG announced today that it entered a co-marketing agreement with Canadian-based CHENOMX Inc. Both enterprises focus on a new and highly promising technology aimed at generating a metabolic profile of the human organism that can be used to monitor the effects of disease, nutrition, toxins, environment, or drugs on an organism.

10 Mar 2010

Study: Hip replacement patients with MoM implants pass metal ions to their infants during pregnancy

Hip replacement patients with metal-on-metal (MoM) implants (both the socket and hip ball are metal) pass metal ions to their infants during pregnancy, according to a new study presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons.

10 Mar 2010

ORNL earns Excellence in Technology Transfer Project of the Year Award

A technology that can enhance collecting of data from studying the compositions on a material surface has earned the Department of Energy's Oak Ridge National Laboratory the Excellence in Technology Transfer Project of the Year Award from the Southeast Region of the Federal Laboratory Consortium for Technology Transfer.

10 Mar 2010

Bruker to acquire certain product lines of Varian

Varian, Inc. announced today that Bruker Corporation and Agilent Technologies, Inc. have entered into a definitive asset purchase agreement pursuant to which Bruker will acquire certain product lines of Varian. As previously announced, Agilent committed to divest those product lines in connection with obtaining regulatory approval for Agilent's pending acquisition of Varian.

9 Mar 2010

AB SCIEX collaborates with Mass Spectrometry Centre to improve drug discovery and development

AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the University of Geneva’s Mass Spectrometry Centre to create new workflows and analytical strategies intended to significantly improve drug discovery and development.

4 Mar 2010

AB SCIEX launches mass-spectrometry-based software application to advance lipid biomarker research

AB SCIEX, a global leader in life science analytical technologies, today announced the launch of the first mass-spectrometry-based software application specifically designed to advance the study of lipidomics.

3 Mar 2010

Consumption of garlic reduces level of potential carcinogenic processes

Researchers have designed a urine test that can simultaneously measure the extent of a potential carcinogenic process and a marker of garlic consumption in humans.

2 Mar 2010

Agilent Technologies launches industry’s first transportable GC/MS system delivering laboratory-quality analysis

Agilent Technologies Inc. today introduced the 5975T Low Thermal Mass (LTM) Gas Chromatography/Mass Spectrometry Detector (GC/MSD), the industry’s first commercial transportable GC/MS system that delivers laboratory-quality analysis. Using proprietary LTM technology, Agilent has developed the 5975T LTM GC/MS to be smaller, more rugged and to consume less power than in-lab GC/MS instruments, yet capable of the same high-quality performance in the field.

2 Mar 2010

Agilent Technologies announces new lab informatics suite at Pittcon 2010

Agilent’s major new lab informatics suite, the OpenLAB portfolio, is designed to enable customers to easily capture, analyze and share scientific data throughout the lab and across the enterprise. OpenLAB is scalable, open architecture based on industry open standards.

2 Mar 2010

MDB Capital Group selects Health Discovery as one of Top 50 “Best and Brightest” companies

Health Discovery Corporation announced today it has been selected by MDB Capital Group as one of its Top 50 “Best and Brightest” companies that will present at the invitation-only, 1st Annual Bright Lights Conference, the first public company conference to focus exclusively on companies with disruptive and market changing intellectual property.

27 Feb 2010

Rapid, multiplexed genotyping method to identify SNPs that affect warfarin dose developed

Researchers from the Ohio State University have developed a rapid, multiplexed genotyping method to identify the single nucleotide polymorphisms (SNPs) that affect warfarin dose. The related report by Yang et al, "Rapid Genotyping of SNPs Influencing Warfarin Drug Response by SELDI-TOF Mass Spectrometry," appears in the March 2010 issue of the Journal of Molecular Diagnostics.

26 Feb 2010

Aetna selects Millennium Laboratories as national pain management services provider

Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, announced today a national agreement with Aetna, one of the nation’s leading diversified health care benefits companies that serves approximately 36.3 million people. Under the terms of the three-year ancillary services agreement which went into effect February 1, 2010, Millennium Laboratories’ will assist Aetna participating physicians nationwide with state-of-the-art therapeutic drug monitoring services and tools.

23 Feb 2010

Spectrometry News and Research

AB SCIEX announces formal opening of Asia Pacific Application Support Center in Shanghai

NMS Labs launches test to evaluate the efficacy of Milnacipran

BIOCIUS Life Sciences executes lease agreement for new Corporate Headquarters in Wakefield, MA

ACS webinar on chemistry for food safety

Pressure BioSciences announces presentations on advantages of PCT

Forensic Laboratories introduces first oral fluid test for Tapentadol

Metal implants in young mothers may pose danger to offspring

PBI and TDI announce strategic licensing and collaborative research and development agreement

BIOCRATES Life Sciences, CHENOMX announce co-marketing agreement

Study: Hip replacement patients with MoM implants pass metal ions to their infants during pregnancy

ORNL earns Excellence in Technology Transfer Project of the Year Award

Bruker to acquire certain product lines of Varian

AB SCIEX collaborates with Mass Spectrometry Centre to improve drug discovery and development

AB SCIEX launches mass-spectrometry-based software application to advance lipid biomarker research

Consumption of garlic reduces level of potential carcinogenic processes

Agilent Technologies launches industry’s first transportable GC/MS system delivering laboratory-quality analysis

Agilent Technologies announces new lab informatics suite at Pittcon 2010

MDB Capital Group selects Health Discovery as one of Top 50 “Best and Brightest” companies

Rapid, multiplexed genotyping method to identify SNPs that affect warfarin dose developed

Aetna selects Millennium Laboratories as national pain management services provider

Innovations in baculovirus–insect cell expression systems

Compound Management and its Crucial Role in Early Pharmaceutical Research

Natural products: the next frontier in drug discovery

Latest News